RecruitingNot Applicable

Understanding of Psychotic Disorders in Children With 22q11.2DS

France80 participantsStarted 2020-11-13

Plain-language summary

The study PremiCeS22 will investigate the prodromal signals at the onset of psychotic disorders of children with 22q11.2 deletion syndrome

Who can participate

Age range4 Years – 13 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of 22q11.2 deletion syndrome or no developmental disease * Aged from 4 to 13 years old * French language Exclusion Criteria: * Diagnosis of intellectual deficiency according to DSM 5 criteria * Drug prescribed for somatic condition that could influence cerebral functioning

What they're measuring

The Screen for child Anxiety Related Emotional Disorders (SCARED)

Timeframe: Day 1

facial expression recognition task

Timeframe: Day 1

Trial details

NCT IDNCT04639388

SponsorHôpital le Vinatier

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06-30

Contact for this trial

Caroline DEMILY, MD PH

0450915163 caroline.demily@ch-le-vinatier.fr

View on ClinicalTrials.gov More 22q11.2 Deletion Syndrome trials